Psilocybin
Bill To Legalize Psychedelics Passes California Senate
The California Senate has passed a bill legalizing the possession of natural psychedelics.
The post Bill To Legalize Psychedelics Passes California Senate…
The California Senate has passed a bill legalizing the possession of natural psychedelics.
Sen. Scott Wiener (D) has been pushing psychedelics bills for years, and has finally succeeded in passing this latest bill through the Senate. This latest bill was approved with a 21-16 vote yesterday and will head to the General Assembly for debate.
SB 58 legalizes specific amounts of psilocybin, psilocyn, DMT, ibogaine and mescaline. This would be for personal or facilitated use and the “possession, preparation, obtaining, transfer, as specified, or transportation…”.
The major difference between this bill and previous attempts was the exclusion of synthetic substances. Psychedelics like LSD and MDMA were not included, with a focus on natural plant entheogens making it more likely to pass the Senate.
The bill allows the following limits on psychedelic possession:
Read the full bill here and see comments from Rep Scott Weiner below.
The Senate just passed our bill (SB 58) to decriminalize possession & use of 5 naturally occurring psychedelics — psilocybin, psilocin, DMT, ibogaine, mescaline.
These substances aren’t addictive & show promise in treating mental health /addiction. Let’s stop criminalizing them.
— Senator Scott Wiener (@Scott_Wiener) May 24, 2023
The post Bill To Legalize Psychedelics Passes California Senate appeared first on Microdose.
mescaline ibogaine psilocybin mdma lsd dmt psychedelic legalize psychedelics-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Law & Regulation1 week ago
Tryp Therapeutics, Exopharm merger approved by shareholders
-
Psychedelics1 week ago
MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
-
LSD1 week ago
The First Wave of Blotter Acid Inspired Trippy Psychedelic Art
-
Law & Regulation1 week ago
Adastra reports record sales in 2023, but remains in the red
-
Psilocybin7 days ago
Psychedelic Underground Celebrated in San Francisco on Bicycle Day Weekend
-
Psychedelics5 days ago
Compass Pathways and Journey Clinical Establish Research Collaboration Agreement To Inform the Training of Healthcare Providers and Delivery Model for COMP360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression